Marketing, Consultancy and Investment

Our venture capital arm was initiated in January 2000 with the establishment of a US$26 million fund. We invest in companies in the ICT, biotechnology and life sciences sectors, focusing on those with high growth market potential, competitive advantage, innovative niche technologies and proven management. Our investments include those in various stages of development and commercialisation, and are spread in various countries including the UK, Korea, Singapore and Malaysia.

We believe in bringing value to our investments, by expanding our role beyond fund provides, to include active management of our portfolio, providing strategic level input, financial advisory and introductions to our wide network.

Our stable of companies has grown to include THG Capital Sdn Bhd (“THG Capital”), a venture capital company, and Amazon Plus Sdn Bhd to undertake asset management and financial advisory services. We also believe in exploiting marketing opportunities in introducing proven technologies and business models from our venture capital network, to this part of the world and have established Strategic Starview Sdn Bhd to spearhead this area.

Other than our own fund, we have launched two partnership funds with other prominent investors. The first partnership fund, Ginosko Technology Investments, is in collaboration with the Singapore Economic Development Board, TIF Ventures Pte Ltd, focusing in investments in the ICT sector. Spring Hill Bioventures, the second fund, is with Khazanah Nasional Berhad, Great Eastern Life Assurance (Malaysia Berhad) and PacificMas Fidelity Sdn Bhd, a US$30 million biotechnology fund, managed by prominent biotech entrepreneur, Dr Kim Tan. The Spring Hill fund has since made numerous investments, including several biotech related projects to be based in Penang.